Author

Erin L. Young

Huntsman Cancer InstituteORCID 0000-0002-7535-006XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Erin L. Young1 paper

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Alexander GuseviD· 1 shared Alison Fraser· 1 shared Amanda GammoniD· 1 shared Angela K. SnowiD· 1 shared Brian D. CromptoniD· 1 shared Bryony A. ThompsoniD· 1 shared Cathryn Koptiuch· 1 shared David E. GoldgariD· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alexander GusevORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Germline predisposition to pediatric Ewing sarcoma is uniquely characterized by inherited pathogenic variants in DNA damage repair genes

Riaz Gillani, Sabrina Yvonne Camp, Seunghun Han, Jill K. Jones, Hoyin Chu, Schuyler O’Brien, Erin L. Young, Lucy Hayes, Gareth Mitchell, Trent Fowler, Alexander Gusev, Junne Kamihara, Katherine A. Janeway, Joshua David Schiffman, Brian D. Crompton, , Eliezer M. Van Allen

This study identifies inherited pathogenic variants in DNA damage repair genes as a distinct germline risk factor for Ewing sarcoma, with FANCC showing significant enrichment.

The American Journal of Human Genetics · May 4, 2022Peer-reviewedGenetic & Genomic Medicine

Universal Panel Testing of Pancreatic Cancer Cases for Cancer Predisposition

Erin L. Young, Bryony A. Thompson, Deborah Wood Neklason, Angela K. Snow, Matthew A. Firpo, Theresa Louise Werner, Russell Bell, Nykole Sutherland, Ken R. Smith, Justin Berger, Alison Fraser, Amanda Gammon, Cathryn Koptiuch, Wendy K. Kohlmann, Leigh A. Neumayer, , Sean V. Tavtigian

This study tests pancreatic cancer cases for germline variants in HBOC and CRC genes, finding 8.9% and 10.5% of cases carry variants with potential clinical significance.

BMC Cancer · Jun 26, 2018Peer-reviewedGenetics